LEITA STARK: Open Payments
NPI 1760719447 · MANTACHIE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,356 in 92 payments from 15 companies in 2025. Trend: 2023 $1,118 · 2024 $1,348 · 2025 $1,356
Food & beverage: $1,356
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $218 |
| Otsuka America Pharmaceutical, Inc. | 9 | $194 |
| PFIZER INC. | 11 | $172 |
| Novo Nordisk Inc | 11 | $167 |
| Lilly USA, LLC | 9 | $154 |
| Amgen Inc. | 7 | $106 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $85 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Ardelyx, Inc. | 2 | $43 |
Products named: REXULTI, MOUNJARO, VRAYLAR, NURTEC ODT, Kerendia, Wegovy, KEVEYIS, ELIQUIS.
Industry payments across MS — which companies pay providers there.
